BackAlpine Immune Sciences Overview

Alpine Immune Sciences Current Assets

Alpine Immune Sciences's current assets is $310M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$308.25M
55.07% YoYΔ $109.47M vs prior year quarter

Peer trimmed avg / median

Loading

Alpine Immune Sciences Current Assets History

Loading

Alpine Immune Sciences vs. peers: Current Assets Comparison

Loading

Alpine Immune Sciences Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Alpine Immune Sciences (ALPN) FAQ

As of the most recent data (March 2024), ALPN shows a current assets of $310M. That compares with $200M in the prior-year period — up 55.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ALPN's current assets is now $310M (was $200M) — a 55.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Alpine Immune Sciences is outperforming or lagging.

Tracking ALPN's current assets over time shows whether Alpine Immune Sciences is scaling, shrinking, or reshaping that part of the business. The current reading is $310M That compares with $200M in the prior-year period — up 55.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Alpine Immune Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $310M) with ownership activity and broader fundamentals.

Alpine Immune Sciences's current assets is $310M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.